Pharma-backed initiative delivers low-cost hep C drugs

 A new program run by charities and academia with the support of pharma is looking to cure 25,000 hep C patients in Africa and Southeast Asia by allowing better access to new drugs. The ministries of Health in Ethiopia, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam have all signed up to…

Read More

US hepatitis C guidelines updated to include new therapies

11 July 2016 The American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America and International Antiviral Society-USA have updated their hepatitis C guidelines to add newly approved direct-acting antiviral (DAA) regimens, offering more options for people with HCV genotypes other than 1 or 4. The…

Read More